The absence of prognostic significance for WBC and Plt may result from patient-specific factors, including previous extensive treatment, heterogeneity of tumor burden, and widespread prophylactic use of G-CSF (overall, G-CSF was used in 68 (81.9%) patients), potentially affecting neutrophil and platelet dynamics [29]. Here, CSF3 is linked to neoplasm.